On Thursday, McEwen Mining Inc (NYSE:MUX)’s shares inclined 6.41% to $0.830.
McEwen Mining Inc. (MUX) declared record quarterly production at the El Gallo Mine in Mexico of 17,325 gold equivalent ounces1, 15% above guidance for the quarter. On a merged basis, gold production for the quarter was 39,164 gold equivalent ounces1.
Highlights
- Record quarterly production at the El Gallo Mine of 17,325 gold equivalent ounces1.
- Total Q2 2015 production of 39,164 gold equivalent ounces1, an enhance of 36% over Q2 2014.
- Year-to-date gold production of 72,598 gold equivalent ounces1, an enhance of 24% over the first six months of 2014.
- Higher average processed gold grade at El Gallo Mine of 3.7 grams per tonne (gpt) vs. 3.2 gpt last quarter.
- Current cash and precious metals of $27.3 million2 $17.3 million2 stated on May 11th, 2015.
Financial Results
Operating costs for Q2 2015 will be released with the Quarterly Financial Statements on August 10th, 2015.
McEwen Mining Inc. explores for, develops, produces, and sells precious and base metals in Argentina, Mexico, and the United States. It primarily explores for gold, silver, and copper. The company’s principal assets comprise of a 49% interest in the San José Mine in Santa Cruz, Argentina; the El Gallo 1 mine and El Gallo 2 project in Sinaloa, Mexico; the Gold Bar project in Nevada, the United States; and the Los Azules copper project in San Juan, Argentina.
NovaGold Resources Inc. (USA) (NYSEMKT:NG)’s shares dropped -0.96% to $3.08.
NOVAGOLD RESOURCES INC. (NG) released its second quarter financial results and updates for its flagship 50%-owned Donlin Gold project (the “Project”) in Alaska and its 50%-owned Galore Creek copper-gold-silver project in British Columbia.
Details of the financial results for the three months ended May 31, 2015 are presented in the merged financial statements and quarterly report filed on Form 10-Q with the SEC that will be accessible on the Company’s website at www.novagold.com, on SEDAR at www.sedar.com, and on EDGAR at www.sec.gov. All amounts are in U.S. dollars unless otherwise stated and all resource and reserve estimates are shown on a 100% project basis.
In the second quarter of 2015, NOVAGOLD achieved the following:
- The Corps addressed all initial comments from the six cooperating agencies preceding to concluding the Donlin Gold preliminary draft EIS, a major step in the permitting process leading to the publication of the draft EIS.
- Community outreach and workforce development initiatives in Alaska continue to be successful with raised efforts through the spring and summer months.
- Calista Corporation leadership visited Barrick Gold’s Goldstrike mine in Nevada, a large-scale gold operation which employs comparable mining and processing equipment to what is envisioned for Donlin Gold, and met with local stakeholders.
NovaGold Resources Inc. explores and develops mineral properties in Canada and the United States. The xcompany primarily explores for gold, silver, and copper deposits. Its flagship project is the 50%-owned Donlin Gold project covering an area of 81,361 acres located in the Kuskokwim region of southwestern Alaska. The company was formerly known as NovaCan Mining Resources (1985) Limited and changed its name to NovaGold Resources Inc. in March 1987.
At the end of Thursday’s trade, Rockwell Medical Inc (NASDAQ:RMTI)‘s shares surged 2.13% to $18.69.
Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, declared recently the publication of the PRIME study results in Kidney International. Triferic is the only iron product FDA approved for delivery via dialysate to replace iron and maintain hemoglobin in hemodialysis patients in the United States.
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease, iron deficiency, secondary hyperparathyroidism, and hemodialysis.
AutoNation, Inc. (NYSE:AN), ended its Thursday’s trading session with 0.49% gain, and closed at $65.99.
AutoNation, Inc. (AN), America’s largest automotive retailer, declared that it will release its financial results for the second quarter of 2015 on Wednesday, July 22, 2015. Mike Jackson, Chairman, Chief Executive Officer and President, Bill Berman, Executive Vice President and Chief Operating Officer, Cheryl Miller, Executive Vice President and Chief Financial Officer, and Jon Ferrando, Executive Vice President responsible for M&A, will talk about these results and other information regarding the Company during a conference call and audio webcast that same day at 11:00 a.m. Eastern Time.
AutoNation, Inc., through its auxiliaries, provides new and used automotive and spare parts retail services in the United States. The company operates in three segments: Domestic, Import, and Premium Luxury. It offers new and used vehicles; parts and services that comprise automotive repair and maintenance services, wholesale parts and collision services; and automotive finance and insurance products, which comprise vehicle services and other protection products, arranging finance for vehicle purchases through third-party finance sources.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
